Latest Insurance News

InhaleRx has corrected its quarterly report and revealed a $38.5 million funding deal to fast-track clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, aiming for FDA approval.

Gathid Ltd reports a strong quarter with a 92% year-on-year increase in Annual Recurring Revenue, new customer wins, and industry recognition, despite ongoing challenges in finalising the sale of its physical security business.

Clime Investment Management has reported a return to profitability in the December half, proposing an interim dividend and unveiling strategic initiatives to drive future growth.

IDT Australia has finalized a $20 million asset-based loan facility with ScotPac, replacing its previous $4.7 million NAB facility, to support its expanding sales pipeline and recent contract wins.

Kogan.com reports robust first-half FY25 results with double-digit growth in sales and profits, driven by strategic marketing and a major digital upgrade at Mighty Ape despite initial setbacks.

Tower Limited has appointed CFO Paul Johnston as interim CEO following Blair Turnbull's resignation, with Deputy CFO Angus Shelton stepping in as interim CFO pending regulatory approval.

FleetPartners Group Limited reported strong FY24 results with record new business writings and assets under management, underpinning a robust growth trajectory and a significant $30 million share buy-back announced for 1H25.

Icetana Limited reports a sharp decline in cash flow for the December quarter, offset by plans for an underwritten rights issue to bolster funding and expectations of improved customer receipts in coming quarters.

BKI Investment Company Limited reported a modest rise in ordinary revenue and declared a 1% higher interim dividend despite a challenging economic backdrop and softer special investment income.

Korvest Ltd reported a 1.1% decline in revenue and a sharp 28.5% drop in net profit for the half-year ending December 2024, impacted by operational disruptions and competitive pressures. Despite these challenges, the company anticipates a robust rebound in project activity in the second half of FY25.

Mirrabooka Investments Limited reported steady half-year profits with a portfolio return of 11.5%, comfortably outperforming its benchmark. The company raised its interim dividend by 12.5%, reflecting confidence in its small and mid-cap investment strategy despite cautious market conditions.